They are the unregulated kind the FDA treats as a serious safety risk, and it is illegal to administer, prescribe, purchase, or dispense them
Your healthcare provider will assess whether Wegovy is appropriate for you based on several factors, including your body mass index (BMI), the presence of weight-related comorbidities, and your overall health status
503A refers to a section of the Federal Food, Drug, and Cosmetic Act for state-licensed compounders
But when people stop taking semaglutide, theres often a rebound weight gain that becomes even more insurmountable than before
Semaglutide accounts for 53% of prescriptions, while liraglutide contributes 47%, reflecting balanced adoption trends
Most of the talk was driven by the powerpoint slides